Fri, May 7, 2021

Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $55 on, May 7th, 2021

Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $60 to $55 on, May 7th, 2021.

Tejas has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $63 on, Wednesday, March 3rd, 2021